Grants and Contributions:
Title:
COVID-19: NITRIC OXIDE NASAL SPRAY AS PREVENTION FOR COVID-19
Agreement Number:
987525
Agreement Value:
$5,500,000.00
Agreement Date:
Feb 14, 2022 - Mar 31, 2024
Description:
To assess the efficacy of a nitric oxide nasal spray (NONS) in the reduction of risk of symptomatic coronavirus disease-19 (COVID-19) infection, reduction of the need for medical intervention resulting from COVID19; and assess tolerability of NONS in participants with COVID-19.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Vancouver, British Columbia, CA V6P 6T3
Reference Number:
172-2021-2022-Q4-987525
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
710549726
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The total amended value is -1,000,000 dollars.
Amendment Date
Nov 20, 2023
Recipient's Operating Name:
SaNOtize
Recipient's Legal Name:
Sanotize Research and Development Corp.
Federal Riding Name:
Vancouver Granville
Federal Riding Number:
59036
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
541710
Amendments: